Menicon Co., Ltd. (TYO:7780)
1,295.00
-1.00 (-0.08%)
Mar 13, 2025, 3:30 PM JST
Menicon Revenue
Menicon had revenue of 30.94B JPY in the quarter ending December 31, 2024, with 5.68% growth. This brings the company's revenue in the last twelve months to 120.30B, up 4.49% year-over-year. In the fiscal year ending March 31, 2024, Menicon had annual revenue of 116.19B with 5.44% growth.
Revenue (ttm)
120.30B
Revenue Growth
+4.49%
P/S Ratio
0.83
Revenue / Employee
28.50M
Employees
4,221
Market Cap
99.49B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 116.19B | 6.00B | 5.44% |
Mar 31, 2023 | 110.19B | 10.02B | 10.00% |
Mar 31, 2022 | 100.17B | 13.96B | 16.20% |
Mar 31, 2021 | 86.21B | 1.69B | 2.00% |
Mar 31, 2020 | 84.52B | 3.62B | 4.48% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Otsuka Holdings | 2,329.86B |
Terumo | 1,011.15B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |